Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

2.37
Delayed Data
As of Apr 29
 -0.05 / -2.07%
Today’s Change
0.80
Today|||52-Week Range
8.96
+95.87%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close2.42
Today’s open2.36
Day’s range2.32 - 2.42
Volume487,689
Average volume (3 months)1,787,056
Market cap$57.6M
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+35.83%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.04+2.90%
CNATConatus Pharmaceutic...+0.02+0.70%
SNTASynta Pharmaceutical...-0.02-4.99%
MSTXMast Therapeutics In...-0.01-1.83%
Data as of 04/29/2016

Financials

Next reporting dateMay 16, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts

Partner Offers

Search for Jobs